Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.7001
+0.0054 (0.78%)
At close: Jun 5, 2026
Lyra Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 0.6 | 1.53 | 1.56 | 1.36 | 0.29 | - | |
Revenue Growth (YoY) | -59.21% | -1.54% | 14.31% | 378.25% | - | - |
Gross Profit | 0.6 | 1.53 | 1.56 | 1.36 | 0.29 | - |
Selling, General & Admin | 12.61 | 18.5 | 19.06 | 17.56 | 14.21 | 9.69 |
Research & Development | 20.4 | 43.77 | 48.03 | 38.8 | 29.69 | 12.52 |
Other Operating Expenses | 2.9 | 35.62 | 1.59 | 1.32 | - | - |
Operating Income | -35.31 | -96.35 | -67.12 | -56.31 | -43.62 | -22.21 |
Interest Income | 1.4 | 2.95 | 4.5 | 1.04 | 0.1 | 0.08 |
Other Non-Operating Income (Expense) | 0.98 | - | - | - | - | - |
Total Non-Operating Income (Expense) | 2.38 | 2.95 | 4.5 | 1.04 | 0.1 | 0.08 |
Pretax Income | -32.93 | -93.4 | -62.62 | -55.27 | -43.51 | -22.13 |
Provision for Income Taxes | -0.02 | -0.04 | -0.06 | -0.01 | - | - |
Net Income | -32.95 | -93.44 | -62.68 | -55.28 | -43.51 | -22.13 |
Net Income to Common | -32.95 | -93.44 | -62.68 | -55.28 | -43.51 | -22.13 |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 |
Shares Change (YoY) | 11.94% | 30.74% | 64.72% | 132.83% | 51.17% | 4150.62% |
EPS (Basic) | -23.44 | -71.50 | -63.00 | -91.50 | -167.50 | -129.50 |
EPS (Diluted) | -23.44 | -71.50 | -63.00 | -91.50 | -167.50 | -129.50 |
Free Cash Flow | -34.11 | -72.35 | -64.35 | -43.55 | -29.21 | -22.92 |
Free Cash Flow Per Share | -23.76 | -55.56 | -64.60 | -72.02 | -112.45 | -133.40 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Operating Margin | -5885.33% | -6280.83% | -4308.09% | -4131.03% | -15303.51% | - |
Profit Margin | -5491.17% | -6090.94% | -4023.11% | -4055.61% | -15267.72% | - |
FCF Margin | -5684.50% | -4716.36% | -4130.36% | -3195.08% | -10247.37% | - |
EBITDA | -34.8 | -95.88 | -66.84 | -55.24 | -42.61 | -22.11 |
EBITDA Margin | -5800.33% | -6250.13% | -4290.24% | -4052.75% | -14952.28% | - |
EBIT | -35.31 | -96.35 | -67.12 | -56.31 | -43.62 | -22.21 |
EBIT Margin | -5885.33% | -6280.83% | -4308.09% | -4131.03% | -15303.51% | - |
Effective Tax Rate | 0.05% | 0.04% | 0.09% | 0.02% | 0.00% | 0.00% |